Proprietary comp report by Overheard on Wall Street.
Harvard's endowment got rekt by private equity and hedge funds, but private equity professionals expect double-digit raises in 2024.
Private equity and venture capital firms from Silicon Valley to Wall Street are pumping millions of dollars into the psychedelic revolution. Investors are betting on the power of mind-bending drugs to transform mental health treatment and cut costs.
Plus: SpaceX strikes $60 billion deal for the right to buy coding startup Cursor, Netflix is buying studio lots at distressed prices, and the Fed's next chair is already drawing lines.
Plus: Jersey Mike's files for an IPO, Apple is getting a new CEO, and direct lending fundraising comes to a standstill.
Plus: A PE billionaire nearing $3.9 billion baseball team deal, bagel chains going national, and Nvidia still in the business of making overnight billionaires.
Plus: Another AI rebrand moons 130%, quantum stocks are ripping too, and private capital is circling the NBA's European expansion.
Plus: Record bank profits come with 5,000 layoffs, and Sydney Sweeney’s American Eagle campaign sends stock soaring.
Plus: Amazon takes aim at Starlink, Goldman creating a bitcoin ETF, and bank execs are telling everyone to stay calm about $100 billion in private credit exposure.
Plus: Goldman’s record quarter, Thoma Bravo exits growth equity, Chicago’s "cheap big city" reputation is failing, and how much protein you actually need.
Plus: Global M&A outlook, state of venture capital, and your social circle.
Plus: Trump pumps Palantir, Wall Street launches CDS tools to bet against private credit, and Barron Trump is launching a herbal tea company.
Plus: Anthropic’s new model is already moving stocks, private credit redemptions keep climbing, and retail investors are getting a shot at the OpenAI IPO.
Plus: TACO trade would've made you 52%, Meta drops new AI model, and incoming Tesla-SpaceX merger?
Plus: TACO trade is back, Ackman wants to buy world’s largest music company, Blackstone raises its largest credit fund in history, and theaters post their strongest run since COVID.
